On August 9, 2019, Kainos Medicine, Inc. (XKON:A220250) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,185 KRW | -2.67% | -3.57% | -3.12% |
2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-3.12% | 84.5M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- A284620 Stock
- News Kainos Medicine, Inc.
- Kainos Medicine, Inc. announced that it has received KRW 3.9999933 billion in funding from NH Investment & Securities Co., Ltd., and another investor